I don't understand why we need FDA's permission to unblind the results of first 120 or so patients. I'd think it's morally imperative in the situation of having already "quite a bit of deaths" in the mortality trial. Why not to stop the trial and save those future placebo deaths if the MtM results confirm our science?
(2)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.